Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT07032662 · RECRUITING
Trial details
- NCT number
- NCT07032662
- Sponsor
- Immunovant Sciences GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2028-08-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.